CompletedNot Applicable

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

United States15 participantsStarted 2008-10

Plain-language summary

This is a 12 week bilateral study, consisting of 6 weeks of treatment and 6 weeks of follow-up. The purpose of the study is to compare the safety and effectiveness of combining and then following a high potency topical corticosteroid treatment with LCD treatment for moderate-to-severe localized plaque psoriasis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age or older * able to provide written informed consent * able to attend study visits, apply medications, and follow instructions * moderate to severe localized plaque psoriasis lesions (\<10% BSA on each side of the body) Exclusion Criteria: * other current treatments for psoriasis * hypersensitivity to steroids, liquor carbonis detergens, alcohol, fragrance * pregnant or nursing

What they're measuring

Percentage of Patients Who Are Clear (PGA Score 0) or Have Minimal Disease (PGA Score 1) on Each Treated Side at Each Visit.

Timeframe: Weeks 2, 6, & 12.

Trial details

NCT IDNCT00769184

SponsorNeoStrata Company, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2009-04

Results submitted2014-11-14

View on ClinicalTrials.gov More Psoriasis trials